News 06 Dic 2021 Roche tests able to detect Omicron The Roche subsidiary TIB Molbiol has developed new coronavirus testing kits that can also detect the new Omicron variant of the disease. These te...
News 01 Dic 2021 Predictive analytics start-up Kido Dynamics raises EUR 1.9 million Kido Dynamics, an EPFL spin-off that helps multiple industries and public institutions to understand and predict people’s mobility, has secured E...
News 22 Set 2021 Switzerland remains a global innovation leader Switzerland has once again topped the Global Innovation Index for this year. In so doing, the world intellectual property organization has determ...
Success stories 25 Mag 2023 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...
Industry Report 22 Mar 2021 Indonesia: Promising production site As the eighth largest economy in the world, Indonesia is already responsible for almost half of the economic output of the Association of Southea...
News 27 Gen 2021 Institute develops double antibody against COVID-19 Researchers at the Institute for Research in Biomedicine have managed to combine two antibodies against COVID-19 into a single entity. This doubl...
News 20 Gen 2021 Swiss PharmaCan successfully tests anti-COVID drug Swiss PharmaCan and Australia-based MGC Pharma have successfully concluded phase II clinical testing for their COVID-19 therapeutic candidate, Ar...
Webinar Supply Chain Exposure: How has the COVID-19 pandemic changed the global picture? 24 Nov 2020 09:00–10:00 Online (CET/MEZ) Svizzera
News 10 Nov 2020 Memo Therapeutics raises 14 million Swiss francs The biotechnology company Memo Therapeutics has raised a total of 14 million Swiss francs as part of a Series B financing round. This should now ...
News 07 Ott 2020 Lonza to start manufacturing Moderna’s Covid-19 vaccine this December Lonza's new building dedicated to the manufacturing of Moderna's Covid-19 vaccine will be operational starting December 2020. 300 million doses w...
Webinar 11 Nov 2020 How MEM companies can deal with travel restrictions While the borders to some countries are reopening, difficulties are still to be expected in other markets. What travel restrictions still apply i...
Expertise 18 Giu 2020 “Costs and efficiency will continue to determine where you produce in future” Will we have to expect a wave of protectionist measures after the coronavirus, or is the opposite more likely? What role will onshoring and nears...
News 16 Set 2020 Lonza set to manufacture coronavirus drug for Humanigen The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonz...
Guide 16 Ott 2020 Tips for safe and healthy travel - Insider tips in Video and Roundtable Are you prepared for your next business trip? Learn how to travel safely and healthily- in a video interview with Gautier Porot, Security Directo...
News 10 Dic 2020 New rules for government tenders in India In the wake of the COVID-19 crises, the government of India has introduced several measures to boost domestic manufacturing and protect micro, sm...
Third Party Event Webinar COVID-19: Challenges and Opportunities in Brazil and Mexico for Swiss Business